ZKB/CALL/SIKA AG/340/0.02/27.09.24 Stock

Warrant

SIKPIZ

CH1305127651

Market Closed - Swiss Exchange 11:20:00 2024-06-17 EDT
0.015 ^CHF	-25.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart SIKA AG

Chart ZKB/CALL/SIKA AG/340/0.02/27.09.24

Latest news about SIKA AG

Environmental, Social and Governance Factors: Sika Committed to Sustainable Performance June 2024	06-13	PU
Swiss Equities Close Higher as Cooling US Inflation Sparks Rate Cut Optimism	06-12	MT
Global markets live: Apple, Oracle, Amazon, Boeing, Tesla...	06-12
Swiss Chemicals Company Sika Opens New Manufacturing Plant in China	06-12	MT

More news

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	SIKA AG
Issuer	ZKB
	SIKPIZ
ISIN	CH1305127651
Date issued	2023-12-19
Strike	340 CHF
Maturity	2024-09-27 (82 Days)
Parity	50 : 1
Emission price	0.11 CHF
Emission volume	N/A
Settlement	les deux
Currency	CHF

Technical Indicators

Highest since issue	0.075 CHF
Lowest since issue	0.015 CHF
Delta	0.04x
Omega	18.56
Premium	31.37x
Gearing	518.4x
Moneyness	0.7624
Difference Strike	80.8 CHF
Difference Strike %	+23.76%
Spread	0.01 CHF
Spread %	66.67%
Theoretical value	0.0100
Implied Volatility	29.83 %
Total Loss Probability	97.42 %
Intrinsic value	0.000000
Present value	0.0100
Break even	340.50 CHF
Theta	-0x
Vega	0x
Rho	0x

Company Profile

Sika AG is the world leader in manufacturing and marketing construction chemicals. Net sales break down by family of products as follows: - construction chemicals (84.1%): admixtures for concretes and mortars, repair mortars, reinforcement and sealing products, sealants, etc.; - industrial manufacturing chemicals (15.9%): adhesives and sealants (mainly polyurethanes, glues, and butyls) primarily for the automotive, railway and shipbuilding sectors. Net sales are distributed geographically as follows: Switzerland (3.5%), France (6%), Europe/Middle East/Africa (30.6%), the United States (21.4%), Americas (9%), China (11.6%), Asia/Pacific (10.4%) and other (7.5%).

Sector

More about the company